Transglutaminase antibodies in children with a genetic risk for celiac disease

E J Hoffenberg1, F Bao, G S Eisenbarth

  • 1Section of Pediatric Gastroenterology, Hepatology, and Nutrition, Center for Pediatric Inflammatory Bowel Diseases, Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, Denver, Colorado, USA.

The Journal of Pediatrics
|September 2, 2000
PubMed

Insights

The transglutaminase (TG) antibody test accurately predicts celiac disease in asymptomatic children with genetic risk. This test identifies children with biopsy-confirmed celiac disease before symptoms manifest.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Genetics

Background:

  • Celiac disease diagnosis in children typically relies on symptomatic presentation.
  • Transglutaminase (TG) antibody testing is a sensitive marker for celiac disease.

Purpose of the Study:

  • To evaluate the positive predictive value of TG antibody testing in asymptomatic children at genetic risk for celiac disease.
  • To explore the correlation between TG antibody titers, small bowel histology, and clinical features in this population.

Main Methods:

  • Asymptomatic children with a known genetic predisposition for celiac disease were enrolled.
  • Small bowel biopsies were performed and histologically graded using the Marsh classification.
  • TG antibody levels were measured and correlated with biopsy findings, growth parameters, and clinical presentation.

Main Results:

  • Among 30 children with positive TG antibody tests, 70% showed definite (Marsh 2 or 3) and 13% showed possible (Marsh 1) biopsy evidence of celiac disease.
  • A significant positive correlation was observed between TG antibody titer and Marsh score (r = 0.569, P <.01).
  • An inverse correlation was found between Marsh score and height z score (r = -0.361, P =.05).

Conclusions:

  • TG antibodies demonstrate a positive predictive value of 70%–83% for biopsy-confirmed celiac disease in asymptomatic, genetically at-risk children.
  • TG antibody testing can identify children with celiac disease prior to the development of overt clinical symptoms.
  • This suggests TG antibody screening is valuable for early detection in at-risk pediatric populations.
Abstract

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...